Syncom Formul.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE312C01025
  • NSEID: SYNCOMF
  • BSEID: 524470
INR
15.16
-0.16 (-1.04%)
BSENSE

Dec 05

BSE+NSE Vol: 1.9 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'17
Mar'16
Mar'15
Net Sales
465.01
263.39
224.25
21,966.32
182.75
181.91
171.04
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
2.35
Total Operating income
465.01
263.39
224.25
21,966.32
182.75
181.91
173.39
Raw Material Cost
278.03
131.53
99.46
9,741.23
69.02
68.90
89.84
Purchase of Finished goods
39.97
27.11
42.61
3,981.41
54.12
66.30
26.90
(Increase) / Decrease In Stocks
-10.66
-1.75
-0.38
331.62
4.97
-3.65
-0.76
Employee Cost
52.17
35.06
25.87
2,215.78
14.62
13.61
13.51
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
-0.01
0.01
0.00
0.00
22.13
25.74
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
51.37
41.80
37.05
3,749.99
25.60
0.00
0.00
Total Expenditure (Excl Depreciation)
410.88
233.74
204.62
20,020.03
168.33
167.29
155.23
Operating Profit (PBDIT) excl Other Income
54.13
29.65
19.63
1,946.29
14.42
14.61
18.16
Other Income
17.43
13.53
14.60
1,199.25
4.86
4.66
1.98
Operating Profit (PBDIT)
71.56
43.18
34.23
3,145.54
19.28
19.27
20.14
Interest
0.86
4.47
3.13
135.52
0.28
0.07
0.21
Exceptional Items
0.01
-0.02
0.01
2.41
0.00
0.00
0.00
Gross Profit (PBDT)
70.71
38.69
31.11
3,012.43
19.00
19.20
19.93
Depreciation
5.19
4.72
4.54
394.84
3.12
3.00
3.43
Profit Before Tax
65.51
33.95
26.57
2,617.59
15.89
16.20
16.49
Tax
16.08
8.64
6.50
638.55
5.34
5.75
5.88
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
49.43
25.31
20.07
1,979.04
10.54
10.46
10.61
Extraordinary Items
0.00
0.00
0.00
0.00
-0.01
-0.10
-0.86
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
49.43
25.31
20.07
1,979.04
10.53
10.36
9.76
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
49.43
25.31
20.07
1,979.04
10.53
10.36
9.76
Equity Capital
94.00
94.00
94.00
8,624.53
78.07
78.06
78.06
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
248.16
194.14
162.01
13,597.63
0.00
30.63
22.16
Earnings per share (EPS)
0.53
0.27
0.21
0.23
0.13
0.13
0.14
Diluted Earnings per share
0.57
0.34
0.24
0.24
0.13
0.13
0.14
Operating Profit Margin (Excl OI)
11.64%
11.26%
8.75%
8.86%
7.89%
8.03%
10.47%
Gross Profit Margin
15.21%
14.69%
13.87%
13.71%
10.4%
10.56%
11.49%
PAT Margin
10.63%
9.61%
8.95%
9.01%
5.77%
5.75%
6.12%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
37.12%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 76.55% vs 17.45% in Mar 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2025 is 95.30% vs 26.11% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 82.56% vs 51.04% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -80.76% vs 42.81% in Mar 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2025 has improved from Mar 2024

Compare Annual Results Of Syncom Formul. With
Markets Mojo
Figures in Cr
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
465.01
809.73
-344.72
-42.57%
Other Operating Income
0.00
0.00
0.00
Total Operating income
465.01
809.73
-344.72
-42.57%
Raw Material Cost
278.03
372.51
-94.48
-25.36%
Purchase of Finished goods
39.97
49.29
-9.32
-18.91%
(Increase) / Decrease In Stocks
-10.66
-8.11
-2.55
-31.44%
Employee Cost
52.17
112.05
-59.88
-53.44%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
51.37
157.30
-105.93
-67.34%
Total Expenditure (Excl Depreciation)
410.88
683.04
-272.16
-39.85%
Operating Profit (PBDIT) excl Other Income
54.13
126.69
-72.56
-57.27%
Other Income
17.43
36.49
-19.06
-52.23%
Operating Profit (PBDIT)
71.56
163.18
-91.62
-56.15%
Interest
0.86
8.12
-7.26
-89.41%
Exceptional Items
0.01
0.00
0.01
Gross Profit (PBDT)
70.71
155.06
-84.35
-54.40%
Depreciation
5.19
29.42
-24.23
-82.36%
Profit Before Tax
65.51
125.64
-60.13
-47.86%
Tax
16.08
35.38
-19.30
-54.55%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
49.43
90.26
-40.83
-45.24%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
49.43
90.26
-40.83
-45.24%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
-5.96
5.96
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
49.43
84.30
-34.87
-41.36%
Equity Capital
94.00
10.54
83.46
791.84%
Face Value
1.00
1.00
0.00
Reserves
248.16
1,039.84
-791.68
-76.13%
Earnings per share (EPS)
0.53
8.00
-7.47
-93.38%
Diluted Earnings per share
0.57
7.95
-7.38
-92.83%
Operating Profit Margin (Excl OI)
11.64%
15.65%
0.00
-4.01%
Gross Profit Margin
15.21%
19.15%
0.00
-3.94%
PAT Margin
10.63%
11.15%
0.00
-0.52%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 465.01 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 76.55% vs 17.45% in Mar 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 49.43 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 95.30% vs 26.11% in Mar 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 54.13 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 82.56% vs 51.04% in Mar 2024

Annual - Interest
Interest 0.86 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -80.76% vs 42.81% in Mar 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 11.64%
in Mar 2025

Figures in %
stock-summary

YoY Growth in year ended Mar 2025 has improved from Mar 2024